Advances in 3D and in vitro models have led to fundamental improvements in human disease modeling, drug development, toxicology testing, and more. As technology advances scientists are integrating human-relevant methods such as tissues-on-chips, 3D bioprinting, organoids, and other in vitro and in silico models into research to produce more reliable results. This talk is the third in a series of four lectures dedicated to exploring methods for more human-relevant testing and research and will focus on in silico and in vitro methods for toxicity testing. In light of the current coronavirus pandemic, the event will be moved online and will also feature discussion of the need for more human-based research for coronavirus therapies and vaccines.
March 27, 2020
1:30pm - 3:30pm MST (4:30pm - 6:30pm EDT)
21st Century Research – Moving Beyond Animals through In Vitro and In Silico Toxicity Testing
• Kristie Sullivan, MPH, Physicians Committee for Responsible Medicine
• Holger Behrsing, PhD, Institute for In Vitro Sciences
• Grace Patlewicz, PhD, US Environmental Protection Agency
This webinar is sponsored by Shamar Advisors and the Early-Career Researchers Advancing 21st Century Science (ERA21) program by the Physicians Committee for Responsible Medicine.
We hope you will join us again for our next webinar on April 24.